FDA clears Abbott glucose-monitoring tool

The FDA has granted Abbott Laboratories approval to market its FreeStyle Navigator system, designed to continuously monitor the blood-sugar levels of diabetics. The device, which was cleared by European regulators last June, will be available in the second quarter of 2008 by prescription.

View Full Article in:

Chicago Sun-Times (free registration) · Wall Street Journal (free content), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Regeneron
Tarrytown, NY
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Active Implantable Medical Device (AIMD) Product Expert
BSI
Nationwide, SL_Nationwide
Finance Manager - ENT
Medtronic
Jacksonville, FL
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA